<DOC>
	<DOCNO>NCT00409240</DOCNO>
	<brief_summary>Our study intend test efficacy pharmacist-led group intervention weekly basis 4-weeks , monthly basis 5 additional month achieve concomitant reduction hemoglobin A1c , lipids blood pressure .</brief_summary>
	<brief_title>Multi-Targeted Cardiac Risk Intervention Type 2 Diabetes</brief_title>
	<detailed_description>Our project intend study 6-month efficacy pharmacist-led group intervention program simultaneously target diabetes , hypertension dyslipidemia . We hypothesize pharmacist-led group intervention weekly basis 4-weeks monthly basis 5 additional month may achieve concomitant reduction hemoglobin A1c , lipids blood pressure . We propose pilot randomize control study test efficacy feasibility approach .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>type 2 diabetes mellitus , &gt; 18 year old , document HbA1c 7.0 % , LDL cholesterol &gt; 100 mg/dl AND blood pressure &gt; 130/80 mm Hg document least medical record within last 6 month , willing comply study intervention eligible study . pregnancy , unable attend group session , disease condition psychiatric instability ( acutely suicidal , psychotic ) organic brain injury preclude perform diabetes selfcare , enrol Providence VAMC 's Telehealth program</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Group Intervention</keyword>
	<keyword>Pharmacotherapy</keyword>
	<keyword>Behavioral Modification</keyword>
	<keyword>Diabetes</keyword>
</DOC>